We are live on ! Find out more
NEXI

NexImmune, Inc. Common Stock

Delisted

NEXI was delisted on the 11th of July, 2024.

44 hedge funds and large institutions have $13.4M invested in NexImmune, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 5 increasing their positions, 13 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% less funds holding

Funds holding: 5244 (-8)

35% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 17

62% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 13

67% less capital invested

Capital invested by funds: $40.1M → $13.4M (-$26.7M)

Holders
44
Holders Change
-8
Holders Change %
-15.38%
% of All Funds
0.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
5
Reduced
13
Closed
17
Calls
Puts
Net Calls
Net Calls Change

NEXI Hedge Fund Activity: Q2 2022 in Review

44 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q2 2022, worth a combined $13.4M — down 67% from $40.1M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of NEXI and 11 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 5 added.

The largest buyer was Kettle Hill Capital Management, opening a new position worth an estimated $675K. The largest seller was BlackRock, cutting an estimated $1.93M.

  • 44 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q2 2022, down from 52 in Q1 2022.
  • Funds reported $13.4M of NexImmune, Inc. Common Stock stock for Q2 2022, down 67% quarter-over-quarter.
  • 11 funds opened new NexImmune, Inc. Common Stock positions in Q2 2022 and 17 closed out, a net change of -6 holders.
  • The largest NexImmune, Inc. Common Stock buyer in Q2 2022 was Kettle Hill Capital Management, an estimated $675K added.
  • The largest NexImmune, Inc. Common Stock seller in Q2 2022 was BlackRock, an estimated $1.93M sold.

Based on aggregated 13F filings for Q2 2022.